Drug Type Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Action antagonists |
Mechanism SSTR antagonists(Somatostatin receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Switzerland | 27 Sep 2024 | |
Colorectal Cancer | Preclinical | Switzerland | 27 Sep 2024 | |
Neuroendocrine Tumors | Preclinical | Switzerland | 03 Aug 2024 |